Resoconto integrale delle discussioni

Mercoledì 13 febbraio 2019 - Strasburgo

16.11. Uso della cannabis a scopo terapeutico (B8-0071/2019) (votazione)

- Prima della votazione sull'emendamento 11:

  Luke Ming Flanagan (GUE/NGL). – Mr President, the reason for the oral amendment is we have left two members of the cannabis family out of what should have been there. It should also include cannabis indica and cannabis ruderalis. Cannabis ruderalis has very low amounts of tetrahydrocannabinol (THC) in comparison to cannabidiol, which is what some people want here and cannabis indica has a better balance of cannabidiol with THC, so if you want to do it right, include this.

  Dubravka Šuica, on behalf of the PPE Group. – Mr President, on behalf of the PPE Group, I object to this oral amendment.

(L'emendamento orale non è accolto vista l'opposizione di oltre 40 deputati presenti in aula)